JOHNSON & JOHNSON
corporate_fare Company Profile
JOHNSON & JOHNSON (NYSE:JNJ) is a publicly traded company in the Life Sciences sector. Wiseek monitors JNJ SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- U.S. Court Disqualifies Key Law Firm from J&J Talc Litigation, Weakening Plaintiffs' Case
- European Commission Approves J&J's AKEEGA for BRCA1/2-Mutated Prostate Cancer
- FDA Approves J&J's Tecvayli for Myeloma; Company Settles Antitrust Claims
- J&J's Nipocalimab Receives FDA Fast Track Designation for Systemic Lupus Erythematosus
- Johnson & Johnson Reports Strong 2025 Earnings, Reverses $7B Talc Reserve, and Announces Orthopaedics Business Separation
Financial Snapshot
Fiscal year ended December 28, 2025
Revenue
$94.19B
Net Income
$26.8B
Diluted EPS
$11.03
Op. Cash Flow
$24.53B
Free Cash Flow
$19.7B
Gross Profit
$63.94B
Cash & Equivalents
$19.71B
Total Debt
$41.44B
Debt / Equity
0.51×
Net Margin
28.5%
Shares Outstanding
2.41B sh
Source: 10-K · filed 2026-02-11 · accession 0000200406-26-000016
show_chartPrice Chart
Loading chart...
feed JNJ - Filings & News (Page 2)
JNJ
Mar 27, 2026, 3:04 PM EDT
Price at Filing:
$241.13
Real-time Price:
$239.55
Change:
-$1.58 (-0.66%)
Market Cap:
$576.649B
JNJ
Mar 09, 2026, 1:07 PM EDT
Price at Filing:
$242.70
Real-time Price:
$239.55
Change:
-$3.15 (-1%)
Market Cap:
$576.649B
JNJ
Mar 06, 2026, 3:03 PM EST
Price at Filing:
$239.28
Real-time Price:
$239.55
Change:
+$0.270 (+0.11%)
Market Cap:
$576.649B
JNJ
Mar 03, 2026, 8:11 AM EST
Price at Filing:
$246.05
Real-time Price:
$239.55
Change:
-$6.50 (-3%)
Market Cap:
$576.649B
JNJ
Feb 11, 2026, 4:06 PM EST
Price at Filing:
$241.13
Real-time Price:
$239.55
Change:
-$1.58 (-0.66%)
Market Cap:
$576.649B
JNJ
Jan 21, 2026, 7:46 AM EST
Price at Filing:
$212.95
Real-time Price:
$239.55
Change:
+$26.60 (+12%)
Market Cap:
$576.649B